क्लिनिकल माइक्रोबायोलॉजी के अभिलेखागार

  • आईएसएसएन: 1989-8436
  • जर्नल एच-इंडेक्स: 22
  • जर्नल उद्धरण स्कोर: 7.55
  • जर्नल प्रभाव कारक: 6.38
में अनुक्रमित
  • जे गेट खोलो
  • जेनेमिक्स जर्नलसीक
  • वैश्विक प्रभाव कारक (जीआईएफ)
  • पुरालेख पहल खोलें
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • रिसर्च जर्नल इंडेक्सिंग की निर्देशिका (डीआरजेआई)
  • ओसीएलसी- वर्ल्डकैट
  • प्रोक्वेस्ट सम्मन
  • पबलोन्स
  • मियार
  • विश्वविद्यालय अनुदान आयोग
  • चिकित्सा शिक्षा और अनुसंधान के लिए जिनेवा फाउंडेशन
  • गूगल ज्ञानी
  • स्किमागो जर्नल रैंकिंग
  • गुप्त खोज इंजन लैब्स
  • अनुसंधान गेट
इस पृष्ठ को साझा करें

अमूर्त

Forming a Non-Profit Organization for Patients with a Urological Disease in 1984: Does it relate to Clinical Microbiology Today?

Vicki Ratner

Interstitial Cystitis (IC), also known as Painful Bladder Syndrome (PBS), was initially described in the mid 1800’s. It was not until 1984 that a patient non-profit organization, the Interstitial Cystitis Association (ICA), was formed in order to work with IC patients and the National Institutes of Health (NIH) to define and increase research on this enigmatic and debilitating condition. The media played an important role in bringing together patients and helping them understand that they were not alone in their suffering. Epidemiological studies legitimized the disease and research at the NIH and other academic institutions progressed enormously. However, despite over 30 years of hard work, urologists have been unable to determine a cause for IC or any truly effective treatments to help patients suffering from this condition. Collaboration with other specialties, in particular clinical microbiology, may prove fruitful in advancing research into the cause and potential treatments for IC.